Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT05834894

Does Muscle Mass At Intensive Care Unit Admission Determine Mortality: the Memo Study

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
4,000 (actual)
Sponsor
University Hospital, Geneva · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

This retrospective monocentric study aims to investigate whether a low muscle mass at ICU admission and its loss over the ICU stay predicts mortality, and in what proportion we can counteract it by nutritional support.

Detailed description

The study hypothesis is that a low muscle mass at ICU admission, measured at the level of L3 on CT scans performed for clinical routine, and its change over the ICU stay predict the prognosis of the patient, especially the 30-day mortality, that it may at least be partly counteracted by nutritional support and that it is related with higher ICU and hospital costs. The objectives of this retrospective study are to determine: 1. the link between baseline body composition at ICU admission and outcomes, such as 30-day, ICU and hospital mortality and LOS, and infections. If this is confirmed, we aim to evaluate the added values of body composition to ICU severity scores to predict 30-day mortality 2. the link between baseline body composition vs. other locations to predict outcomes 3. the impact of body composition changes on the afore-mentioned outcomes. If this is confirmed, we aim to evaluate the added value of changes in body composition to changes in ICU severity scores to predict 30-day mortality 4. the impact of nutritional support on body composition changes

Conditions

Interventions

TypeNameDescription
OTHERexposure(s) of interest : intensive care unitLow muscle mass is highly prevalent at hospital admission, and muscle mass generally decreases during hospital stay, especially in critically-ill patients. We would like to mesure muscle mas in critically ill patients and determine the association between outcomes.

Timeline

Start date
2010-01-01
Primary completion
2025-05-31
Completion
2025-10-31
First posted
2023-04-28
Last updated
2024-12-06

Locations

1 site across 1 country: Switzerland

Source: ClinicalTrials.gov record NCT05834894. Inclusion in this directory is not an endorsement.